nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—CYP3A4—Temozolomide—malignant glioma	0.215	1	CbGbCtD
Bosentan—Hydrocephalus—Carmustine—malignant glioma	0.0531	0.11	CcSEcCtD
Bosentan—Venoocclusive disease—Carmustine—malignant glioma	0.0434	0.0903	CcSEcCtD
Bosentan—Hemiparesis—Temozolomide—malignant glioma	0.0231	0.048	CcSEcCtD
Bosentan—Leg edema—Temozolomide—malignant glioma	0.0179	0.0374	CcSEcCtD
Bosentan—Traumatic liver injury—Temozolomide—malignant glioma	0.013	0.027	CcSEcCtD
Bosentan—Liver injury—Temozolomide—malignant glioma	0.00574	0.012	CcSEcCtD
Bosentan—Disturbance in attention—Temozolomide—malignant glioma	0.00558	0.0116	CcSEcCtD
Bosentan—Respiratory failure—Temozolomide—malignant glioma	0.00492	0.0102	CcSEcCtD
Bosentan—Musculoskeletal pain—Temozolomide—malignant glioma	0.00489	0.0102	CcSEcCtD
Bosentan—Influenza like illness—Temozolomide—malignant glioma	0.00469	0.00977	CcSEcCtD
Bosentan—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00403	0.0084	CcSEcCtD
Bosentan—Gastroenteritis—Temozolomide—malignant glioma	0.00396	0.00824	CcSEcCtD
Bosentan—Hepatic failure—Temozolomide—malignant glioma	0.0039	0.00813	CcSEcCtD
Bosentan—Nasal congestion—Temozolomide—malignant glioma	0.00385	0.00802	CcSEcCtD
Bosentan—Thirst—Temozolomide—malignant glioma	0.00369	0.00768	CcSEcCtD
Bosentan—Hyponatraemia—Carmustine—malignant glioma	0.00365	0.00759	CcSEcCtD
Bosentan—Affect lability—Temozolomide—malignant glioma	0.00345	0.00719	CcSEcCtD
Bosentan—Liver function test abnormal—Carmustine—malignant glioma	0.00335	0.00698	CcSEcCtD
Bosentan—Mood swings—Temozolomide—malignant glioma	0.00332	0.00692	CcSEcCtD
Bosentan—Hypokalaemia—Carmustine—malignant glioma	0.0033	0.00688	CcSEcCtD
Bosentan—Dehydration—Temozolomide—malignant glioma	0.00326	0.00679	CcSEcCtD
Bosentan—Dry skin—Temozolomide—malignant glioma	0.00322	0.0067	CcSEcCtD
Bosentan—Hypokalaemia—Temozolomide—malignant glioma	0.00319	0.00665	CcSEcCtD
Bosentan—Abdominal distension—Temozolomide—malignant glioma	0.00305	0.00636	CcSEcCtD
Bosentan—Sweating increased—Temozolomide—malignant glioma	0.00295	0.00615	CcSEcCtD
Bosentan—Neutropenia—Carmustine—malignant glioma	0.00293	0.00611	CcSEcCtD
Bosentan—Bronchitis—Temozolomide—malignant glioma	0.00292	0.00607	CcSEcCtD
Bosentan—Dysuria—Temozolomide—malignant glioma	0.00284	0.0059	CcSEcCtD
Bosentan—Neutropenia—Temozolomide—malignant glioma	0.00284	0.0059	CcSEcCtD
Bosentan—Hyperglycaemia—Carmustine—malignant glioma	0.00283	0.00589	CcSEcCtD
Bosentan—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00282	0.00587	CcSEcCtD
Bosentan—Pneumonia—Carmustine—malignant glioma	0.00281	0.00586	CcSEcCtD
Bosentan—Pollakiuria—Temozolomide—malignant glioma	0.0028	0.00583	CcSEcCtD
Bosentan—Weight increased—Temozolomide—malignant glioma	0.00276	0.00575	CcSEcCtD
Bosentan—Renal failure—Carmustine—malignant glioma	0.00275	0.00573	CcSEcCtD
Bosentan—Weight decreased—Temozolomide—malignant glioma	0.00274	0.00571	CcSEcCtD
Bosentan—Hyperglycaemia—Temozolomide—malignant glioma	0.00274	0.0057	CcSEcCtD
Bosentan—Stomatitis—Carmustine—malignant glioma	0.00273	0.00568	CcSEcCtD
Bosentan—Urinary tract infection—Carmustine—malignant glioma	0.00272	0.00566	CcSEcCtD
Bosentan—Pneumonia—Temozolomide—malignant glioma	0.00272	0.00566	CcSEcCtD
Bosentan—Infestation—Temozolomide—malignant glioma	0.0027	0.00563	CcSEcCtD
Bosentan—Infestation NOS—Temozolomide—malignant glioma	0.0027	0.00563	CcSEcCtD
Bosentan—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00268	0.00558	CcSEcCtD
Bosentan—Stomatitis—Temozolomide—malignant glioma	0.00264	0.00549	CcSEcCtD
Bosentan—Urinary tract infection—Temozolomide—malignant glioma	0.00263	0.00547	CcSEcCtD
Bosentan—Hepatobiliary disease—Temozolomide—malignant glioma	0.00256	0.00532	CcSEcCtD
Bosentan—Sinusitis—Temozolomide—malignant glioma	0.00254	0.00528	CcSEcCtD
Bosentan—Haemoglobin—Carmustine—malignant glioma	0.00252	0.00526	CcSEcCtD
Bosentan—Haemorrhage—Carmustine—malignant glioma	0.00251	0.00523	CcSEcCtD
Bosentan—Hypoaesthesia—Carmustine—malignant glioma	0.0025	0.0052	CcSEcCtD
Bosentan—Oedema peripheral—Carmustine—malignant glioma	0.00247	0.00515	CcSEcCtD
Bosentan—Haemoglobin—Temozolomide—malignant glioma	0.00244	0.00508	CcSEcCtD
Bosentan—Haemorrhage—Temozolomide—malignant glioma	0.00243	0.00505	CcSEcCtD
Bosentan—Hepatitis—Temozolomide—malignant glioma	0.00243	0.00505	CcSEcCtD
Bosentan—Hypoaesthesia—Temozolomide—malignant glioma	0.00242	0.00503	CcSEcCtD
Bosentan—Urinary tract disorder—Temozolomide—malignant glioma	0.0024	0.00499	CcSEcCtD
Bosentan—Oedema peripheral—Temozolomide—malignant glioma	0.00239	0.00498	CcSEcCtD
Bosentan—Urethral disorder—Temozolomide—malignant glioma	0.00238	0.00495	CcSEcCtD
Bosentan—Eye disorder—Carmustine—malignant glioma	0.00235	0.00489	CcSEcCtD
Bosentan—Flushing—Carmustine—malignant glioma	0.00233	0.00485	CcSEcCtD
Bosentan—Erythema multiforme—Temozolomide—malignant glioma	0.0023	0.00478	CcSEcCtD
Bosentan—Eye disorder—Temozolomide—malignant glioma	0.00227	0.00472	CcSEcCtD
Bosentan—Tinnitus—Temozolomide—malignant glioma	0.00226	0.00471	CcSEcCtD
Bosentan—Cardiac disorder—Temozolomide—malignant glioma	0.00225	0.00469	CcSEcCtD
Bosentan—Flushing—Temozolomide—malignant glioma	0.00225	0.00469	CcSEcCtD
Bosentan—Angiopathy—Temozolomide—malignant glioma	0.0022	0.00458	CcSEcCtD
Bosentan—Mental disorder—Carmustine—malignant glioma	0.0022	0.00458	CcSEcCtD
Bosentan—Immune system disorder—Temozolomide—malignant glioma	0.00219	0.00456	CcSEcCtD
Bosentan—Mediastinal disorder—Temozolomide—malignant glioma	0.00219	0.00455	CcSEcCtD
Bosentan—Malnutrition—Carmustine—malignant glioma	0.00219	0.00455	CcSEcCtD
Bosentan—Erythema—Carmustine—malignant glioma	0.00219	0.00455	CcSEcCtD
Bosentan—Chills—Temozolomide—malignant glioma	0.00218	0.00453	CcSEcCtD
Bosentan—Mental disorder—Temozolomide—malignant glioma	0.00213	0.00443	CcSEcCtD
Bosentan—Back pain—Carmustine—malignant glioma	0.00212	0.0044	CcSEcCtD
Bosentan—Erythema—Temozolomide—malignant glioma	0.00211	0.0044	CcSEcCtD
Bosentan—Malnutrition—Temozolomide—malignant glioma	0.00211	0.0044	CcSEcCtD
Bosentan—Vision blurred—Carmustine—malignant glioma	0.00206	0.00429	CcSEcCtD
Bosentan—Tremor—Carmustine—malignant glioma	0.00205	0.00426	CcSEcCtD
Bosentan—Back pain—Temozolomide—malignant glioma	0.00204	0.00426	CcSEcCtD
Bosentan—Anaemia—Carmustine—malignant glioma	0.00202	0.00421	CcSEcCtD
Bosentan—Vision blurred—Temozolomide—malignant glioma	0.00199	0.00415	CcSEcCtD
Bosentan—Tremor—Temozolomide—malignant glioma	0.00198	0.00412	CcSEcCtD
Bosentan—Leukopenia—Carmustine—malignant glioma	0.00196	0.00407	CcSEcCtD
Bosentan—Anaemia—Temozolomide—malignant glioma	0.00195	0.00407	CcSEcCtD
Bosentan—Angioedema—Temozolomide—malignant glioma	0.00193	0.00402	CcSEcCtD
Bosentan—Vertigo—Temozolomide—malignant glioma	0.0019	0.00395	CcSEcCtD
Bosentan—Leukopenia—Temozolomide—malignant glioma	0.00189	0.00394	CcSEcCtD
Bosentan—Palpitations—Temozolomide—malignant glioma	0.00187	0.00389	CcSEcCtD
Bosentan—Chest pain—Carmustine—malignant glioma	0.00186	0.00388	CcSEcCtD
Bosentan—Anxiety—Carmustine—malignant glioma	0.00186	0.00386	CcSEcCtD
Bosentan—Cough—Temozolomide—malignant glioma	0.00184	0.00384	CcSEcCtD
Bosentan—Arthralgia—Temozolomide—malignant glioma	0.0018	0.00375	CcSEcCtD
Bosentan—Anxiety—Temozolomide—malignant glioma	0.00179	0.00373	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00179	0.00372	CcSEcCtD
Bosentan—Oedema—Carmustine—malignant glioma	0.00178	0.00372	CcSEcCtD
Bosentan—Discomfort—Temozolomide—malignant glioma	0.00178	0.0037	CcSEcCtD
Bosentan—Infection—Carmustine—malignant glioma	0.00177	0.00369	CcSEcCtD
Bosentan—Dry mouth—Temozolomide—malignant glioma	0.00176	0.00366	CcSEcCtD
Bosentan—Thrombocytopenia—Carmustine—malignant glioma	0.00175	0.00364	CcSEcCtD
Bosentan—Tachycardia—Carmustine—malignant glioma	0.00174	0.00363	CcSEcCtD
Bosentan—Anaphylactic shock—Temozolomide—malignant glioma	0.00172	0.00359	CcSEcCtD
Bosentan—Oedema—Temozolomide—malignant glioma	0.00172	0.00359	CcSEcCtD
Bosentan—Infection—Temozolomide—malignant glioma	0.00171	0.00357	CcSEcCtD
Bosentan—Anorexia—Carmustine—malignant glioma	0.0017	0.00354	CcSEcCtD
Bosentan—Nervous system disorder—Temozolomide—malignant glioma	0.00169	0.00352	CcSEcCtD
Bosentan—Thrombocytopenia—Temozolomide—malignant glioma	0.00169	0.00352	CcSEcCtD
Bosentan—Skin disorder—Temozolomide—malignant glioma	0.00168	0.00349	CcSEcCtD
Bosentan—Hypotension—Carmustine—malignant glioma	0.00167	0.00347	CcSEcCtD
Bosentan—Hyperhidrosis—Temozolomide—malignant glioma	0.00167	0.00347	CcSEcCtD
Bosentan—Anorexia—Temozolomide—malignant glioma	0.00164	0.00342	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00163	0.00338	CcSEcCtD
Bosentan—Insomnia—Carmustine—malignant glioma	0.00161	0.00336	CcSEcCtD
Bosentan—Paraesthesia—Carmustine—malignant glioma	0.0016	0.00334	CcSEcCtD
Bosentan—Dyspnoea—Carmustine—malignant glioma	0.00159	0.00331	CcSEcCtD
Bosentan—Somnolence—Carmustine—malignant glioma	0.00159	0.0033	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00157	0.00327	CcSEcCtD
Bosentan—Insomnia—Temozolomide—malignant glioma	0.00156	0.00325	CcSEcCtD
Bosentan—Decreased appetite—Carmustine—malignant glioma	0.00155	0.00323	CcSEcCtD
Bosentan—Paraesthesia—Temozolomide—malignant glioma	0.00155	0.00322	CcSEcCtD
Bosentan—Gastrointestinal disorder—Carmustine—malignant glioma	0.00154	0.00321	CcSEcCtD
Bosentan—Dyspnoea—Temozolomide—malignant glioma	0.00154	0.0032	CcSEcCtD
Bosentan—Somnolence—Temozolomide—malignant glioma	0.00153	0.00319	CcSEcCtD
Bosentan—Constipation—Carmustine—malignant glioma	0.00153	0.00318	CcSEcCtD
Bosentan—Pain—Carmustine—malignant glioma	0.00153	0.00318	CcSEcCtD
Bosentan—Dyspepsia—Temozolomide—malignant glioma	0.00152	0.00316	CcSEcCtD
Bosentan—Decreased appetite—Temozolomide—malignant glioma	0.0015	0.00312	CcSEcCtD
Bosentan—EDNRB—retina—malignant glioma	0.00149	0.155	CbGeAlD
Bosentan—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00149	0.0031	CcSEcCtD
Bosentan—Fatigue—Temozolomide—malignant glioma	0.00149	0.0031	CcSEcCtD
Bosentan—Pain—Temozolomide—malignant glioma	0.00147	0.00307	CcSEcCtD
Bosentan—Constipation—Temozolomide—malignant glioma	0.00147	0.00307	CcSEcCtD
Bosentan—Gastrointestinal pain—Carmustine—malignant glioma	0.00146	0.00304	CcSEcCtD
Bosentan—Abdominal pain—Carmustine—malignant glioma	0.00141	0.00294	CcSEcCtD
Bosentan—Body temperature increased—Carmustine—malignant glioma	0.00141	0.00294	CcSEcCtD
Bosentan—Gastrointestinal pain—Temozolomide—malignant glioma	0.00141	0.00294	CcSEcCtD
Bosentan—EDNRB—telencephalon—malignant glioma	0.00137	0.142	CbGeAlD
Bosentan—Urticaria—Temozolomide—malignant glioma	0.00137	0.00285	CcSEcCtD
Bosentan—Body temperature increased—Temozolomide—malignant glioma	0.00136	0.00284	CcSEcCtD
Bosentan—Abdominal pain—Temozolomide—malignant glioma	0.00136	0.00284	CcSEcCtD
Bosentan—Hypersensitivity—Carmustine—malignant glioma	0.00131	0.00274	CcSEcCtD
Bosentan—Asthenia—Carmustine—malignant glioma	0.00128	0.00267	CcSEcCtD
Bosentan—Hypersensitivity—Temozolomide—malignant glioma	0.00127	0.00265	CcSEcCtD
Bosentan—Asthenia—Temozolomide—malignant glioma	0.00124	0.00258	CcSEcCtD
Bosentan—Diarrhoea—Carmustine—malignant glioma	0.00122	0.00254	CcSEcCtD
Bosentan—Pruritus—Temozolomide—malignant glioma	0.00122	0.00254	CcSEcCtD
Bosentan—Dizziness—Carmustine—malignant glioma	0.00118	0.00246	CcSEcCtD
Bosentan—Diarrhoea—Temozolomide—malignant glioma	0.00118	0.00246	CcSEcCtD
Bosentan—Dizziness—Temozolomide—malignant glioma	0.00114	0.00237	CcSEcCtD
Bosentan—Vomiting—Carmustine—malignant glioma	0.00113	0.00236	CcSEcCtD
Bosentan—Rash—Carmustine—malignant glioma	0.00113	0.00234	CcSEcCtD
Bosentan—Dermatitis—Carmustine—malignant glioma	0.00112	0.00234	CcSEcCtD
Bosentan—Headache—Carmustine—malignant glioma	0.00112	0.00233	CcSEcCtD
Bosentan—Vomiting—Temozolomide—malignant glioma	0.0011	0.00228	CcSEcCtD
Bosentan—Rash—Temozolomide—malignant glioma	0.00109	0.00226	CcSEcCtD
Bosentan—Dermatitis—Temozolomide—malignant glioma	0.00109	0.00226	CcSEcCtD
Bosentan—Headache—Temozolomide—malignant glioma	0.00108	0.00225	CcSEcCtD
Bosentan—EDNRB—medulla oblongata—malignant glioma	0.00108	0.112	CbGeAlD
Bosentan—Nausea—Carmustine—malignant glioma	0.00106	0.00221	CcSEcCtD
Bosentan—Nausea—Temozolomide—malignant glioma	0.00102	0.00213	CcSEcCtD
Bosentan—EDNRB—midbrain—malignant glioma	0.000986	0.102	CbGeAlD
Bosentan—EDNRB—spinal cord—malignant glioma	0.000962	0.0996	CbGeAlD
Bosentan—EDNRA—medulla oblongata—malignant glioma	0.000892	0.0923	CbGeAlD
Bosentan—EDNRA—midbrain—malignant glioma	0.000815	0.0844	CbGeAlD
Bosentan—EDNRB—cerebellum—malignant glioma	0.000763	0.079	CbGeAlD
Bosentan—EDNRB—brain—malignant glioma	0.00062	0.0641	CbGeAlD
Bosentan—EDNRA—brain—malignant glioma	0.000512	0.053	CbGeAlD
Bosentan—EDNRA—Signaling Pathways—HIST1H3B—malignant glioma	0.000287	0.000975	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—FBXW7—malignant glioma	0.000286	0.000972	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—BDKRB2—malignant glioma	0.000281	0.000953	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—F2—malignant glioma	0.00028	0.000949	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—IDH2—malignant glioma	0.00028	0.000949	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CXCL8—malignant glioma	0.000275	0.000932	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—MMP3—malignant glioma	0.000274	0.000931	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—AKT2—malignant glioma	0.00027	0.000915	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—PIK3CG—malignant glioma	0.000268	0.000908	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000264	0.000895	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—PTPN11—malignant glioma	0.000263	0.000892	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP2B6—malignant glioma	0.000263	0.000892	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—JAG2—malignant glioma	0.000262	0.00089	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NOTCH2—malignant glioma	0.000261	0.000886	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—PIK3CD—malignant glioma	0.000259	0.000879	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—KNG1—malignant glioma	0.000256	0.000867	CbGpPWpGaD
Bosentan—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000254	0.000862	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—RTEL1—malignant glioma	0.000252	0.000856	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.000249	0.000846	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.000246	0.000835	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—AKT2—malignant glioma	0.000245	0.000831	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NTRK1—malignant glioma	0.000244	0.000826	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—IDH1—malignant glioma	0.00024	0.000816	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000237	0.000805	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—PIK3CD—malignant glioma	0.000235	0.000798	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—SPHK1—malignant glioma	0.000233	0.000789	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP2C18—malignant glioma	0.000228	0.000773	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MMP3—malignant glioma	0.000226	0.000768	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—PIK3CB—malignant glioma	0.000226	0.000766	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CDKN2B—malignant glioma	0.000224	0.000762	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000222	0.000755	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—H3F3A—malignant glioma	0.000222	0.000753	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—F2—malignant glioma	0.00022	0.000748	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCR3—malignant glioma	0.00022	0.000746	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PTK2—malignant glioma	0.000218	0.00074	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CXCL8—malignant glioma	0.000217	0.000736	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000215	0.000729	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—HES1—malignant glioma	0.000214	0.000726	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NTRK2—malignant glioma	0.000214	0.000726	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—YWHAE—malignant glioma	0.000214	0.000726	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NCOR1—malignant glioma	0.000213	0.000722	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FLT1—malignant glioma	0.000213	0.000722	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—DUSP6—malignant glioma	0.000212	0.000719	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PIK3CG—malignant glioma	0.000211	0.000716	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—RAF1—malignant glioma	0.00021	0.000713	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—JAG1—malignant glioma	0.000209	0.00071	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NOTCH3—malignant glioma	0.000208	0.000707	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—IL2—malignant glioma	0.000207	0.000704	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—PIK3CB—malignant glioma	0.000205	0.000696	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FBXW7—malignant glioma	0.000205	0.000696	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PDGFRA—malignant glioma	0.000204	0.000692	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—BDKRB2—malignant glioma	0.000201	0.000682	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—F2—malignant glioma	0.0002	0.000679	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SPP1—malignant glioma	0.000198	0.000672	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CXCL8—malignant glioma	0.000197	0.000669	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000196	0.000664	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—AKT2—malignant glioma	0.000193	0.000655	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PIK3CG—malignant glioma	0.000192	0.00065	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000189	0.000641	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL2—malignant glioma	0.000188	0.000639	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PTPN11—malignant glioma	0.000188	0.000638	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TERT—malignant glioma	0.000188	0.000637	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NOTCH2—malignant glioma	0.000187	0.000634	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PIK3CD—malignant glioma	0.000185	0.000629	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTT1—malignant glioma	0.000184	0.000625	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PDGFB—malignant glioma	0.000183	0.000621	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—KNG1—malignant glioma	0.000183	0.000621	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—FGFR1—malignant glioma	0.000182	0.000618	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00018	0.000612	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—HIF1A—malignant glioma	0.000179	0.000609	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—AKT2—malignant glioma	0.000175	0.000595	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000174	0.000592	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NTRK1—malignant glioma	0.000174	0.000591	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CAV1—malignant glioma	0.000174	0.000589	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PTGS1—malignant glioma	0.000173	0.000586	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000172	0.000584	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—KDR—malignant glioma	0.000172	0.000582	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PIK3CD—malignant glioma	0.000168	0.000571	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000166	0.000564	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—F2—malignant glioma	0.000165	0.00056	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—FN1—malignant glioma	0.000165	0.00056	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000165	0.000558	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—BAD—malignant glioma	0.000163	0.000554	CbGpPWpGaD
Bosentan—CYP3A4—central nervous system—malignant glioma	0.000163	0.0169	CbGeAlD
Bosentan—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000162	0.000551	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MMP3—malignant glioma	0.000162	0.00055	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NOTCH1—malignant glioma	0.000162	0.000548	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PIK3CB—malignant glioma	0.000162	0.000548	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CDKN2B—malignant glioma	0.000161	0.000545	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—BCHE—malignant glioma	0.000161	0.000545	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—SLC5A5—malignant glioma	0.000159	0.000538	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CD80—malignant glioma	0.000158	0.000537	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—APC—malignant glioma	0.000158	0.000536	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PIK3CG—malignant glioma	0.000158	0.000536	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—EGF—malignant glioma	0.000156	0.00053	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PTK2—malignant glioma	0.000156	0.000529	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PTPN11—malignant glioma	0.000155	0.000527	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CXCL8—malignant glioma	0.000155	0.000527	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HES1—malignant glioma	0.000153	0.00052	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NCOR1—malignant glioma	0.000152	0.000517	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—RAF1—malignant glioma	0.00015	0.00051	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.00015	0.000509	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000149	0.000504	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—BRAF—malignant glioma	0.000149	0.000504	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—IL2—malignant glioma	0.000148	0.000504	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PIK3CB—malignant glioma	0.000147	0.000498	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PDGFRA—malignant glioma	0.000146	0.000495	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—COX8A—malignant glioma	0.000145	0.000492	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—AKT2—malignant glioma	0.000145	0.000491	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—EGFR—malignant glioma	0.000144	0.000489	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SPP1—malignant glioma	0.000142	0.000481	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CXCL8—malignant glioma	0.000141	0.000478	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PIK3CD—malignant glioma	0.000139	0.000472	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—PIK3CA—malignant glioma	0.000138	0.000467	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—KRAS—malignant glioma	0.000136	0.000462	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL2—malignant glioma	0.000135	0.000457	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TERT—malignant glioma	0.000134	0.000456	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—FGF2—malignant glioma	0.000133	0.000451	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PDGFB—malignant glioma	0.000131	0.000445	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FGFR1—malignant glioma	0.00013	0.000442	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.00013	0.00044	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000129	0.000439	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HIF1A—malignant glioma	0.000128	0.000436	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTP1—malignant glioma	0.000128	0.000434	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—PIK3CA—malignant glioma	0.000125	0.000424	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MDM2—malignant glioma	0.000124	0.000422	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CAT—malignant glioma	0.000124	0.000422	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CAV1—malignant glioma	0.000124	0.000421	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—RAF1—malignant glioma	0.000124	0.000421	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ASMT—malignant glioma	0.000123	0.000418	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—KDR—malignant glioma	0.000123	0.000417	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—ERBB2—malignant glioma	0.000123	0.000416	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PIK3CB—malignant glioma	0.000121	0.000411	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.00012	0.000408	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FN1—malignant glioma	0.000118	0.000401	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—F2—malignant glioma	0.000118	0.000401	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—NCOR1—malignant glioma	0.000117	0.000398	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—BAD—malignant glioma	0.000117	0.000396	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCL8—malignant glioma	0.000116	0.000395	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—BCAN—malignant glioma	0.000116	0.000393	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NOTCH1—malignant glioma	0.000116	0.000393	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CD80—malignant glioma	0.000113	0.000385	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3CG—malignant glioma	0.000113	0.000384	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—APC—malignant glioma	0.000113	0.000384	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—AKT1—malignant glioma	0.000112	0.000382	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EGF—malignant glioma	0.000112	0.000379	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CASP3—malignant glioma	0.000111	0.000378	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL2—malignant glioma	0.000111	0.000377	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PTPN11—malignant glioma	0.000111	0.000377	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—BRAF—malignant glioma	0.000106	0.000361	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MMP9—malignant glioma	0.000105	0.000357	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PTEN—malignant glioma	0.000105	0.000355	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AKT2—malignant glioma	0.000104	0.000351	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—EGFR—malignant glioma	0.000103	0.00035	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—AKT1—malignant glioma	0.000102	0.000346	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3CD—malignant glioma	9.95e-05	0.000337	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PIK3CA—malignant glioma	9.85e-05	0.000334	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—KRAS—malignant glioma	9.74e-05	0.00033	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CAV1—malignant glioma	9.57e-05	0.000325	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—COX8A—malignant glioma	9.55e-05	0.000324	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FGF2—malignant glioma	9.52e-05	0.000323	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—VEGFA—malignant glioma	9.45e-05	0.000321	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—STAT3—malignant glioma	9.36e-05	0.000318	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—IDH2—malignant glioma	9.34e-05	0.000317	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.14e-05	0.00031	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PIK3CA—malignant glioma	8.95e-05	0.000304	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MDM2—malignant glioma	8.91e-05	0.000302	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—RAF1—malignant glioma	8.88e-05	0.000301	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	8.8e-05	0.000299	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ERBB2—malignant glioma	8.78e-05	0.000298	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP2B6—malignant glioma	8.78e-05	0.000298	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3CG—malignant glioma	8.72e-05	0.000296	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MYC—malignant glioma	8.7e-05	0.000295	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3CB—malignant glioma	8.67e-05	0.000294	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—EGFR—malignant glioma	8.51e-05	0.000289	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPARG—malignant glioma	8.41e-05	0.000286	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCL8—malignant glioma	8.33e-05	0.000283	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ASMT—malignant glioma	8.12e-05	0.000276	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—AKT1—malignant glioma	8.05e-05	0.000273	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—KRAS—malignant glioma	8.04e-05	0.000273	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—IDH1—malignant glioma	8.03e-05	0.000272	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CASP3—malignant glioma	7.97e-05	0.000271	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL2—malignant glioma	7.96e-05	0.00027	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SPHK1—malignant glioma	7.77e-05	0.000264	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3CD—malignant glioma	7.66e-05	0.00026	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—BCAN—malignant glioma	7.64e-05	0.000259	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP2C18—malignant glioma	7.61e-05	0.000258	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MMP9—malignant glioma	7.53e-05	0.000256	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PTEN—malignant glioma	7.49e-05	0.000254	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PIK3CA—malignant glioma	7.38e-05	0.000251	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—AKT1—malignant glioma	7.31e-05	0.000248	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	7.18e-05	0.000243	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TP53—malignant glioma	7.14e-05	0.000242	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—VEGFA—malignant glioma	6.77e-05	0.00023	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—STAT3—malignant glioma	6.7e-05	0.000227	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3CB—malignant glioma	6.68e-05	0.000227	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PTGS2—malignant glioma	6.62e-05	0.000225	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.54e-05	0.000222	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.31e-05	0.000214	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MYC—malignant glioma	6.23e-05	0.000211	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—IDH2—malignant glioma	6.16e-05	0.000209	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTT1—malignant glioma	6.15e-05	0.000209	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EGFR—malignant glioma	6.09e-05	0.000207	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—AKT1—malignant glioma	6.03e-05	0.000205	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP2B6—malignant glioma	5.79e-05	0.000196	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PTEN—malignant glioma	5.77e-05	0.000196	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PTGS1—malignant glioma	5.77e-05	0.000196	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—KRAS—malignant glioma	5.75e-05	0.000195	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.75e-05	0.000195	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—BCHE—malignant glioma	5.36e-05	0.000182	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SLC5A5—malignant glioma	5.3e-05	0.00018	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—IDH1—malignant glioma	5.29e-05	0.00018	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3CA—malignant glioma	5.28e-05	0.000179	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SPHK1—malignant glioma	5.12e-05	0.000174	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TP53—malignant glioma	5.11e-05	0.000173	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP2C18—malignant glioma	5.02e-05	0.00017	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.01e-05	0.00017	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.96e-05	0.000168	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.33e-05	0.000147	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AKT1—malignant glioma	4.32e-05	0.000146	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTP1—malignant glioma	4.27e-05	0.000145	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CAT—malignant glioma	4.15e-05	0.000141	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3CA—malignant glioma	4.07e-05	0.000138	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTT1—malignant glioma	4.06e-05	0.000138	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NCOR1—malignant glioma	3.92e-05	0.000133	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTGS1—malignant glioma	3.8e-05	0.000129	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—BCHE—malignant glioma	3.54e-05	0.00012	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.49e-05	0.000119	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—AKT1—malignant glioma	3.33e-05	0.000113	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CAV1—malignant glioma	3.2e-05	0.000108	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.05e-05	0.000104	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3CG—malignant glioma	2.91e-05	9.88e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTP1—malignant glioma	2.81e-05	9.55e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPARG—malignant glioma	2.81e-05	9.53e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CAT—malignant glioma	2.74e-05	9.29e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NCOR1—malignant glioma	2.59e-05	8.77e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3CD—malignant glioma	2.56e-05	8.68e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.23e-05	7.57e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PTGS2—malignant glioma	2.21e-05	7.5e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CAV1—malignant glioma	2.11e-05	7.15e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PTEN—malignant glioma	1.93e-05	6.54e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.92e-05	6.51e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPARG—malignant glioma	1.85e-05	6.29e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.69e-05	5.73e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.47e-05	4.99e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTGS2—malignant glioma	1.46e-05	4.95e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.36e-05	4.61e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTEN—malignant glioma	1.27e-05	4.31e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AKT1—malignant glioma	1.11e-05	3.77e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3CA—malignant glioma	8.97e-06	3.04e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AKT1—malignant glioma	7.33e-06	2.49e-05	CbGpPWpGaD
